About this document

Jurnal Nefro 1 by Nisa winanda is a document available to read on EtoBox.

This meta-analysis evaluates the efficacy of SGLT2 inhibitors in reducing the risk of acute kidney injury (AKI) among patients with chronic kidney disease, cardiovascular disease, and type 2 diabetes. The analysis of eight studies involving 65,606 patients found that SGLT2 inhibitors significantly lower the risk of AKI, particularly in patients with higher initial eGFR levels, while showing no significant effect in those with eGFR below 45 mL/min/1.73 m². The findings suggest that while SGLT2 inhibitors are

Author

Nisa winanda

Language

EN